Creating Biomedical Technologies to Improve Health



NIBIB in the News • October 1, 2012
Hari Shroff, Chief, Section on High Resolution Optical Imaging at NIBIB was one of four microscopy innovators/researchers asked to discuss novel approaches in his lab. Shroff works on high-resolution imaging of zebrafish embryonic development. Since super high resolution microscopy techniques typically cannot be applied to live samples because they are both slow and relatively toxic to the cells, he has built a system that couples the super-resolution of Structured Illumination Imaging (SIM) and confocal microscopy–a technique that allows him to image samples several cell layers deep. Read the full article from The Scientist.
Grantee News • September 24, 2012

Dr. Joachim Kohn, AFIRM's Director and an NIBIB Principal Investigator, takes people ravaged by war and helps discover new ways to put them (literally) back together through tissue engineering, renerative processes like bone and nerve repair, face transplants, human transplantation, and an engineered skin substitute for burns. Read the full article from

Press Releases • September 17, 2012
Six projects have been awarded funding to develop robots that can interact and work cooperatively with people and respond to changing environments in a variety of healthcare applications, the National Institutes of Health, collaborating with three other federal agencies, announced last week. The total amount for these projects over the next four years amounts to $4.4M, subject to the availability of funds.
NIBIB in the News • September 12, 2012
Howard Hughes Medical Institute announces funding of graduate biomedical training awards in collaboration with NIBIB. William Heetderks comments on importance of training for biomedical researchers and NIBIB-HHMI collaboration. Read the full article from the Howard Hughes Medical Institute.
Grantee News • September 4, 2012

A new study by University of Kentucky researchers, carried out in the laboratory of Pexiuan Guo, an NIBIB PI, shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to cancers without harming surrounding tissue. Read the full article from University of Kentucky.

Grantee News • September 4, 2012

Point-of-care tests for chlamydia as developed by NIBIB-funded researcher Charlotte Gaydos are more cost-effective than traditional nucleic acid amplification test (NAAT) in a clinic when specified characteristics (sensitivity, specificity, cost, and willingness to wait in a clinic for POC test results) are met. Read the full article from Johns Hopkins.

Science Highlights • August 30, 2012
How much radiation in medical tests is too much? NIBIB is taking a central role on an initiative to develop new methods and technologies for reducing the radiation dose from routine CT scans while maintaining the high quality of the images produced.
Press Releases • August 2, 2012
On Tuesday, NIBIB announced the winners in the three categories of the DEBUT challenge, a biomedical engineering design competition for teams of undergraduate students. The three categories addressed the critical needs in biomedical technology, focusing on devices for diagnostics and therapeutics as well as technology that can aid underserved populations and individuals with disabilities.
Press Releases • August 2, 2012
Three projects aimed at enhancing interdisciplinary training for graduate students have won awards from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), part of the National Institutes of Health, and the Howard Hughes Medical Institute (HHMI).The awards are part of a joint Interfaces Initiative partnership program that recognizes the importance of interdisciplinary research for the advancement of biomedical science.
Grantee News • July 9, 2012
NIBIB funded researcher, David Kaplan, at Tufts University has discovered a new silk stabilization technology to preserve vaccines and antiobiotics without refrigeration. Read the full article from Tufts University.